Cardiovascular effects of diabetes drugs: Making the dark ages brighter with CAROLINA

Annals of Internal Medicine

Volumn 158, Issue 6, 2013, Pages 499-

  Rosenstock, Julio ^a   Marx, Nikolaus ^b   Johansen, Odd Erik ^c   Wörle, Hans Jürgen ^c  

^a DALLAS DIABETES AND ENDOCRINE CENTER AT MEDICAL CITY   (United States)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c Boehringer Ingleheim   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLIMEPIRIDE; LINAGLIPTIN; SULFONYLUREA;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CLINICAL DECISION MAKING; COMPARATIVE STUDY; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY;

EID: 84879869972     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-6-201303190-00017     Document Type: Letter

References (5)

1. Nissen SE. Cardiovascular effects of diabetes drugs: emerging from the dark ages. Ann Intern Med. 2012;157:671-2. [PMID: 23128866]
2. Roumie CL, Hung AM, Greevy RA, Grijalva CG, Liu X, Murff HJ, et al. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2012;157:601-10. [PMID: 23128859]
3. Zeller M, Danchin N, Simon D, Vahanian A, Lorgis L, Cottin Y, et al; French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction investigators. Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction. J Clin Endocrinol Metab. 2010;95:4993-5002. [PMID: 20702526]
4. Nathan DM. Time for clinically relevant comparative effectiveness studies in type 2 diabetes [Editorial]. Ann Intern Med. 2011;154:131-2. [PMID: 21135287]
5. Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011;154:602-13. [PMID: 21403054]